Overview
Familial gastric type 1 neuroendocrine tumor is a rare inherited condition in which small, slow-growing tumors develop in the lining of the stomach. These tumors arise from special hormone-producing cells called enterochromaffin-like (ECL) cells. In the familial form, the condition runs in families and is linked to an underlying tendency to develop autoimmune gastritis, a condition where the immune system attacks the stomach lining. This leads to a loss of acid-producing cells, which causes the body to produce excess amounts of a hormone called gastrin. The high gastrin levels stimulate the ECL cells to grow abnormally, eventually forming small tumors (also called gastric carcinoids). Many people with this condition have no symptoms at all, and the tumors are often found during an upper endoscopy done for other reasons. When symptoms do occur, they may include stomach discomfort, nausea, or signs of vitamin B12 deficiency such as fatigue and anemia. In rare cases, the tumors may cause flushing or other symptoms related to hormone release. Type 1 gastric neuroendocrine tumors are generally considered low-grade and have a good prognosis. Treatment typically involves regular monitoring with endoscopy and removal of polyps when found. In most cases, these tumors do not spread to other parts of the body. However, because this is a familial condition, family members may also need screening. Treatment options range from endoscopic removal of tumors to medications that reduce gastrin levels, and in rare advanced cases, surgery may be considered.
Key symptoms:
Stomach discomfort or painNauseaFatigue due to anemiaVitamin B12 deficiencyPale skin from low red blood cell countFeeling full quickly after eatingTingling or numbness in hands and feet from B12 deficiencyOccasional heartburn or indigestionUnintended weight lossFlushing of the skin (rare)Diarrhea (uncommon)Weakness and low energy
Variable
Can be inherited in different ways depending on the underlying gene
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
1 eventDetectnet: FDA approved
indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Familial gastric type 1 neuroendocrine tumor.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Familial gastric type 1 neuroendocrine tumor at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Familial gastric type 1 neuroendocrine tumor.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Familial gastric type 1 neuroendocrine tumor.
Community
No community posts yet. Be the first to share your experience with Familial gastric type 1 neuroendocrine tumor.
Start the conversation →Latest news about Familial gastric type 1 neuroendocrine tumor
No recent news articles for Familial gastric type 1 neuroendocrine tumor.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How often will I need an endoscopy, and what will you be looking for each time?,Should my family members be screened for this condition, and if so, how?,Do I need genetic testing, and what would the results mean for my family?,What are the signs that a tumor might be becoming more aggressive?,Will I need vitamin B12 injections for the rest of my life?,Are there any medications that can help prevent new tumors from forming?,What lifestyle changes or dietary adjustments should I make?
Common questions about Familial gastric type 1 neuroendocrine tumor
What is Familial gastric type 1 neuroendocrine tumor?
Familial gastric type 1 neuroendocrine tumor is a rare inherited condition in which small, slow-growing tumors develop in the lining of the stomach. These tumors arise from special hormone-producing cells called enterochromaffin-like (ECL) cells. In the familial form, the condition runs in families and is linked to an underlying tendency to develop autoimmune gastritis, a condition where the immune system attacks the stomach lining. This leads to a loss of acid-producing cells, which causes the body to produce excess amounts of a hormone called gastrin. The high gastrin levels stimulate the EC
At what age does Familial gastric type 1 neuroendocrine tumor typically begin?
Typical onset of Familial gastric type 1 neuroendocrine tumor is adult. Age of onset can vary across affected individuals.